oasis-1 oral semaglutide 50 mg obesity nejm 2023 Daily GLP-1 Receptor Agonist Orforglipron for Adults with Low Dose Oral Semaglutide for

RiveraFBCruzLLAMagalongJVRuyerasJApareceJPBantayanNRBet al

Metabolic Resistance Point GLP-1 therapy is most strategically introduced when patients exhibit metabolic adaptations that counteract behavioral interventions: Plateau Effect: GLP-1 should be considered when patients adhering to a caloric deficit and exercise program experience a weight plateau, indicating a reduction in Total Daily Energy Expenditure (TDEE) as a physiological defense

From there, strategic use of peptide stacks, metabolic therapies, and recovery protocols can be layered in to support long-term performance and longevity

doi: 10.1186/s40360-020-00447-w

We dont focus on restrictions, or quick fixes that you wont stick to